MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations

Tumor Biology

Volumn 37, Issue 5, 2016, Pages 6637-6645

  Ozcan, Onder ^a   Kara, Murat ^a   Yumrutas, Onder ^b   Bozgeyik, Esra ^c   Bozgeyik, Ibrahim ^b   Celik, Ozgur Ilhan ^a  

^a MUGLA SITKI KOCMAN UNIVERSITY   (Turkey)

^b ADIYAMAN UNIVERSITY   (Turkey)

^c GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Colorectal cancer; miR 135b 5p; miR 183 5p; miR 373 3p; miRNA; MTUS1

Indexed keywords

MICRORNA; MICRORNA 125A 5P; MICRORNA 125B 5P; MICRORNA 135B 5P; MICRORNA 142 5P; MICRORNA 181A 5P; MICRORNA 181D 5P; MICRORNA 183 5P; MICRORNA 184; MICRORNA 19A 3P; MICRORNA 200C 3P; MICRORNA 20A 5P; MICRORNA 27B 3P; MICRORNA 372 3P; MICRORNA 373 3P; MICRORNA 98 5P; MICRORNA LET 7A 5P; MICRORNA LET 7B 5P; MICRORNA LET 7C 5P; MICRORNA LET 7D 5P; MICRORNA LET 7E 5P; MICRORNA LET 7F 5P; MICRORNA LET 7G 5P; MICRORNA LET 7I 5P; UNCLASSIFIED DRUG; MTUS1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; CANCER PATIENT; CANCER TISSUE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MTUS1 GENE; PREDICTION; PRIORITY JOURNAL; RNA ANALYSIS; TUMOR SUPPRESSOR GENE; UPREGULATION; VALIDATION STUDY; AGED; BINDING SITE; BIOLOGY; CANCER STAGING; CASE CONTROL STUDY; CLUSTER ANALYSIS; COLORECTAL TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METASTASIS; MIDDLE AGED; NUCLEIC ACID DATABASE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROCEDURES; RNA INTERFERENCE; TUMOR CELL LINE;

ADULT; AGED; BASE SEQUENCE; BINDING SITES; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEINS;

EID: 84949512540     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4550-4     Document Type: Article

References (51)

1. Geyik E, Igci YZ, Pala E, Suner A, Borazan E, Bozgeyik I, Bayraktar E, Bayraktar R, Ergun S, Cakmak EA, Gokalp A, Arslan A: Investigation of the association between ATP2b4 and ATP5b genes with colorectal cancer. Gene. 2014;540:178-182
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: Cancer J Clin. 2012;62:10–29.
3. Centelles JJ: General aspects of colorectal cancer. ISRN oncology 2012;2012
4. Di Benedetto M, Bieche I, Deshayes F, Vacher S, Nouet S, Collura V, et al. Structural organization and expression of human mtus1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin ii at2 receptor-interacting proteins, atip. Gene. 2006;380:127–36.
5. Ding X, Zhang N, Cai Y, Li S, Zheng C, Jin Y, et al. Down-regulation of tumor suppressor mtus1/atip is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma. Mol Oncol. 2012;6:73–80.
6. Frank B, Bermejo JL, Hemminki K, Sutter C, Wappenschmidt B, Meindl A, et al. Copy number variant in the candidate tumor suppressor gene mtus1 and familial breast cancer risk. Carcinogenesis. 2007;28:1442–5.
7. Pils D, Horak P, Gleiss A, Sax C, Fabjani G, Moebus VJ, et al. Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma. Cancer. 2005;104:2417–29.
8. Seibold S, Rudroff C, Weber M, Galle J, Wanner C, Marx M. Identification of a new tumor suppressor gene located at chromosome 8p21. 3-22. FASEB J. 2003;17:1180–2.
9. Ye H, Pungpravat N, Huang B-L, Muzio LL, Mariggio MA, Chen Z, et al. Genomic assessments of the frequent loss of heterozygosity region on 8p21. 3-p22 in head and neck squamous cell carcinoma. Cancer Genet Cytogenet. 2007;176:100–6.
10. Schetter AJ, Okayama H, Harris CC. The role of micrornas in colorectal cancer. Cancer J (Sudbury, Mass). 2012;18:244.
11. Chen J, Wang W, Zhang Y, Hu T, Chen Y. The roles of mir-200c in colon cancer and associated molecular mechanisms. Tumor Biol. 2014;35:6475–83.
12. Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, Koike J, et al. Microrna-200c modulates epithelial-to-mesenchymal transition (emt) in human colorectal cancer metastasis. Gut. 2013;62:1315–26.
13. Song C, Liu LZ, Pei XQ, Liu X, Yang L, Ye F, Xie X, Chen J, Tang H: Mir-200c inhibits breast cancer proliferation by targeting kras. Oncotarget 2015
14. Gattolliat C-H, Uguen A, Pesson M, Trillet K, Simon B, Doucet L, et al. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas. Eur J Cancer. 2015;51:409–20.
15. Paraskevopoulou MD, Georgakilas G, Kostoulas N, Vlachos IS, Vergoulis T, Reczko M, et al. Diana-microt web server v5. 0: Service integration into mirna functional analysis workflows. Nucleic Acids Res. 2013;41:W169–73.
16. Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG. Functional microRNA targets in protein coding sequences. Bioinformatics. 2012;28:771–6.
17. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15–20.
18. Li J-H, Liu S, Zhou H, Qu L-H, Yang J-H: Starbase v2. 0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale clip-seq data. Nucleic acids research 2013:gkt1248.
19. Yang J-H, Li J-H, Shao P, Zhou H, Chen Y-Q, Qu L-H. Starbase: a database for exploring microRNA-mRNA interaction maps from argonaute clip-seq and degradome-seq data. Nucleic Acids Res. 2011;39:D202–9.
20. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008;36:D149–53.
21. Wang X. Mirdb: a microRNA target prediction and functional annotation database with a wiki interface. RNA. 2008;14:1012–7.
22. Wang X, El Naqa IM. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics. 2008;24:325–32.
23. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.
24. Kara M, Yumrutas O, Ozcan O, Celik OI, Bozgeyik E, Bozgeyik I, Tasdemir S: Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene 2015
25. Rehmsmeier M, Steffen P, Höchsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA. 2004;10:1507–17.
26. Chan KL, Man-Fong Lee J, Guan XY, Fan ST, Oi-Lin Ng I. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation. Cancer. 2002;94:3179–85.
27. Zuern C, Heimrich J, Kaufmann R, Richter KK, Settmacher U, Wanner C, et al. Down-regulation of mtus1 in human colon tumors. Oncol Rep. 2010;23:183–9.
28. Nouet S, Amzallag N, Li J-M, Louis S, Seitz I, Cui T-X, et al. Trans-inactivation of receptor tyrosine kinases by novel angiotensin ii at2 receptor-interacting protein, atip. J Biol Chem. 2004;279:28989–97.
29. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes mir15 and mir16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci. 2002;99:15524–9.
30. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, et al. Identification by real-time pcr of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer. 2006;5:29.
31. Nagel R, le Sage C, Diosdado B, van der Waal M, Vrielink JAFO, Bolijn A, et al. Regulation of the adenomatous polyposis coli gene by the mir-135 family in colorectal cancer. Cancer Res. 2008;68:5795–802.
32. Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J. Circulating serum miRNA (mir-367-3p, mir-371a-3p, mir-372-3p and mir-373-3p) as biomarkers in patients with testicular germ cell cancer. J Urol. 2015;193:331–7.
33. Wu A, Li J, Wu K, Mo Y, Luo Y, Ye H, et al. Mir-373-3p promotes invasion and metastasis of lung adenocarcinoma cells. Zhongguo fei ai za zhi=. Chinese J lung Cancer. 2014;18:427–35.
34. Sarver AL, Li L, Subramanian S. MicroRNA mir-183 functions as an oncogene by targeting the transcription factor egr1 and promoting tumor cell migration. Cancer Res. 2010;70:9570–80.
35. Tang J-F, Yu Z-H, Liu T, Lin Z-Y, Wang Y-H, Yang L-W, et al. Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma. Asian Pacific J Cancer Prevention: APJCP. 2013;15:7575–81.
36. Chang C-W, Wu H-C, Terry MB, Santella RM. MicroRNA expression in prospectively collected blood as a potential biomarker of breast cancer risk in the BCFR. Anticancer Res. 2015;35:3969–77.
37. Wang L, Zhu M-J, Ren A-M, Wu H-F, Han W-M, Tan R-Y, Tu R-Q: A ten-microRNA signature identified from a genome-wide microRNA expression profiling in human epithelial ovarian cancer. 2014
38. Bandras E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer. 2006;5:29.
39. Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui J, Liu Y, Gao Z, Li J, Shen L: Combination of hsa-mir-375 and hsa-mir-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Annals of oncology 2011:mdq758.
40. Jo DH, Kim JH, Park W-Y, Kim K-W, Yu YS, Kim JH. Differential profiles of microRNAs in retinoblastoma cell lines of different proliferation and adherence patterns. J Pediatr Hematol Oncol. 2011;33:529–33.
41. Saito Y, Suzuki H, Tsugawa H, Imaeda H, Matsuzaki J, Hirata K, Hosoe N, Nakamura M, Mukai M, Saito H: Overexpression of mir-142-5p and mir-155 in gastric mucosa-associated lymphoid tissue (malt) lymphoma resistant to helicobacter pylori eradication. 2012
42. Balci S, Ayaz L, Gorur A, Yildirim Yaroglu H, Akbayir S, Dogruer Unal N, Bulut B, Tursen U, Tamer L: MicroRNA profiling for early detection of nonmelanoma skin cancer. Clinical and experimental dermatology 2015
43. Ibarrola-Villava M, Llorca-Cardenosa MJ, Tarazona N, Mongort C, Fleitas T, Perez-Fidalgo JA, Rosello S, Navarro S, Ribas G, Cervantes A: Deregulation of arid1a, cdh1, cmet and pik3ca and target-related microRNA expression in gastric cancer. Oncotarget 2015
44. Zhi F, Shao N, Wang R, Deng D, Xue L, Wang Q, Zhang Y, Shi Y, Xia X, Wang S: Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. Neuro-oncology 2014:nou169.
45. Wen Y, Han J, Chen J, Dong J, Xia Y, Liu J, Jiang Y, Dai J, Lu J, Jin G: Plasma mirnas as early biomarkers for detecting hepatocellular carcinoma. International journal of cancer 2015
46. Ye S-B, Li Z-L, Luo D-h, Huang B-j, Chen Y-S, Zhang X-S, et al. Tumor-derived exosomes promote tumor progression and t-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5:5439.
47. Calvano Filho CMC, Calvano-Mendes DC, Carvalho KC, Maciel GA, Ricci MD, Torres AP, et al. Triple-negative and luminal a breast tumors: differential expression of mir-18a-5p, mir-17-5p, and mir-20a-5p. Tumor Biol. 2014;35:7733–41.
48. Chen X, Shi K, Wang Y, Song M, Zhou W, Tu H, Lin Z: Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation. Oncotarget 2015
49. Li Y, Kuscu C, Banach A, Zhang Q, Pulkoski-Gross A, Kim D, Liu J, Roth E, Li E, Shroyer KR: MicroRNA-181a-5p inhibits cancer cell migration and angiogenesis via downregulation of matrix metalloproteinase-14. Cancer research 2015:canres. 2875.2014.
50. Ma Z, Qiu X, Wang D, Li Y, Zhang B, Yuan T, et al. Mir-181a-5p inhibits cell proliferation and migration by targeting kras in non-small cell lung cancer a549 cells. Acta Biochim Biophys Sin. 2015;47:630–8.
51. He S, Zeng S, Zhou Z-W, He Z-X, Zhou S-F. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication. Drug Des Devel and Ther. 2015;9:1103.